光大证券晨会速递-20251211

Macro Analysis - The November CPI year-on-year growth rate has expanded, primarily due to a low base effect and an unusual seasonal increase in fresh vegetable prices [1] - The core CPI year-on-year growth rate has stabilized, with rising gold prices continuing to exert influence, while the "old-for-new" policy has weakened support for durable goods prices [1] - PPI has continued to rise month-on-month, but the year-on-year decline has slightly widened due to last year's base effect [1] - In terms of structure, upstream coal and non-ferrous prices are leading the increase, while midstream equipment manufacturing prices have improved, and downstream consumer manufacturing prices have stabilized, reflecting a continuous "anti-involution" effect [1] Industry Research - The recent release of the new medical insurance directory and the first commercial insurance innovative drug directory indicates a successful negotiation rate of 88% for basic medical insurance, the highest in seven years [2] - The first commercial insurance directory includes 19 types of drugs, with a negotiation success rate of 79% [2] - The expansion and quality improvement of the medical insurance directory support the high-quality development of innovative drugs, with a strict approval rate of 41.48% for drugs outside the directory [2] - The collaboration between the two directories supports "true innovation" and "differentiated innovation" in the pharmaceutical sector, with recommendations to focus on companies like Heng Rui Medicine, BeiGene, Innovent Biologics, and CanSino Biologics [2] Company Research - The company under study, Lao Pu Gold, has achieved high-quality market penetration by designing products around classic cultural elements from both Eastern and Western traditions, appealing to younger consumers [3] - The company’s stores are concentrated in high-end commercial areas, aligning with the luxurious image of ancient gold, and while the number of stores is limited, the output per store is significant [3] - The online strategy accelerates the penetration of ancient gold, attracting young customers through low total price and low weight products, which also support long-term offline development [3] - The projected net profit for the company from 2025 to 2027 is estimated at 4.763 billion, 6.541 billion, and 8.449 billion yuan, respectively, with a current PE ratio of 21, 15, and 12 times, and a target price of 804.64 HKD, initiating a "buy" rating [3]